Valeant auc­tions off Den­dreon, skin­care as­sets; Bay­er to col­lab­o­rate with the Uni­ver­si­ty of Pitts­burgh

• A trou­bled Valeant has struck a deal to sell Den­dreon and its prostate can­cer vac­cine Provenge to Chi­na’s San­pow­er Group for $820 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.